Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation

Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation

Body mass index (BMI) influences the prognosis of patients with non-small cell lung cancer (NSCLC), including both early-stage and late-stage NSCLC patients that are undergoing chemotherapies. However, earlier research on the relationship between BMI and survival in patients taking epidermal growth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu-Mu Chen, Chien-Hao Lai, Chiung-Yu Lin, Yi-Hsuan Tsai, Ya-Chun Chang, Hung-Chen Chen, Chia-Cheng Tseng, Huang-Chih Chang, Kuo-Tung Huang, Yung-Che Chen, Wen-Feng Fang, Chin-Chou Wang, Tung-Ying Chao, Meng-Chih Lin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
body mass index
weight loss
non-small cell lung cancer
tyrosine kinase inhibitor
Nutrition. Foods and food supply
TX341-641
Acceso en línea:https://doaj.org/article/f6b4a7988ca7414f8acc45de727e6885
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f6b4a7988ca7414f8acc45de727e6885

Ejemplares similares